Cargando…
Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer
We have recently demonstrated that the transcription factor MYB can modulate several cancer-associated phenotypes in pancreatic cancer. In order to understand the molecular basis of these MYB-associated changes, we conducted deep-sequencing of transcriptome of MYB-overexpressing and -silenced pancre...
Autores principales: | Azim, Shafquat, Zubair, Haseeb, Srivastava, Sanjeev K., Bhardwaj, Arun, Zubair, Asif, Ahmad, Aamir, Singh, Seema, Khushman, Moh’d., Singh, Ajay P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926062/ https://www.ncbi.nlm.nih.gov/pubmed/27354262 http://dx.doi.org/10.1038/srep28446 |
Ejemplares similares
-
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
por: Khan, Mohammad Aslam, et al.
Publicado: (2017) -
MYB is a novel regulator of pancreatic tumour growth and metastasis
por: Srivastava, Sanjeev K, et al.
Publicado: (2015) -
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
por: Patel, Girijesh Kumar, et al.
Publicado: (2017) -
Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications
por: Patel, Girijesh Kumar, et al.
Publicado: (2019) -
Cancer Chemoprevention by Phytochemicals: Nature’s Healing Touch
por: Zubair, Haseeb, et al.
Publicado: (2017)